Quoin Pharmaceuticals ( ($QNRX) ) has shared an update. On October 10, 2025, Quoin Pharmaceuticals announced a private placement agreement with ...
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...
In a statement, Cabaletta CEO Steven Nichtberger, M.D., highlighted Gavel’s previous experience commercializing cell ...
The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with distinct vascular and cardiopulmonary features.
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...
Clinical Laboratory Services Market: The clinical laboratory services market will grow from $297.5 Bn in 2025 to $396.8 Bn by ...
Kris Aquino has slammed another death hoax about her saying she's currently in isolation amid her battle with multiple ...
A new study from South Korea has found that a common type of diabetes medicine may offer an unexpected benefit: a lower risk ...
Previous research investigating sex differences in brain ageing has shown mixed results, Ravndal adds. Several studies have ...